[Federal Register Volume 82, Number 46 (Friday, March 10, 2017)]
[Notices]
[Pages 13351-13352]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-04742]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and STD 
Prevention and Treatment

AGENCY: Health Resources and Services Administration, Department of 
Health and Human Services (HHS).

ACTION: Notice of meeting.

-----------------------------------------------------------------------

SUMMARY: In accordance with the Federal Advisory Committee Act, notice 
is hereby given that a meeting is scheduled for the Centers for Disease 
Control and Prevention (CDC)/Health Resources and Services 
Administration (HRSA) Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment. This meeting will be open to the public. 
Information about the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment and the meeting agenda can 
be obtained by contacting CDR Holly Berilla at (301) 443-9965 or 
[email protected].

DATES: The meeting will be held on March 30, 2017, from 2:00 p.m. to 
3:00 p.m. (Eastern).

ADDRESSES: The meeting will be held virtually with telephone access 
that will accommodate up to 100 attendees and is open to the public. 
Parties may access the teleconference by dialing 888-566-6570 and using 
participant code: 1682061. Participants should call and connect 15 
minutes prior to the start of the meeting.

FOR FURTHER INFORMATION CONTACT: Anyone requesting information 
regarding the CDC/HRSA Advisory Committee on HIV, Viral Hepatitis and 
STD Prevention and Treatment should contact CDR Holly Berilla, Public 
Health Analyst, HRSA, HIV/AIDS Bureau (HAB), Division of Policy and 
Data (DPD), in one of three ways: (1) Send a request to the following 
address: CDR Holly Berilla, Public Health Analyst, HRSA, HAB, DPD, 5600 
Fishers Lane, Rockville, Maryland 20857; (2) call 301-443-9965; or (3) 
send an email to [email protected].

SUPPLEMENTARY INFORMATION: The CDC/HRSA Advisory Committee on HIV, 
Viral Hepatitis and STD Prevention and Treatment was established under 
Section 222 of the Public Health Service

[[Page 13352]]

Act (42 U.S.C. Section 217a), as amended.
    The purpose of the CDC/HRSA Advisory Committee on HIV, Viral 
Hepatitis and STD Prevention and Treatment is to advise the Secretary 
of HHS, the Director of CDC, and the Administrator of HRSA regarding 
objectives, strategies, policies, and priorities for HIV, viral 
hepatitis, and other STDs; prevention and treatment efforts including 
surveillance of HIV infection, AIDS, viral hepatitis, and other STDs, 
and related behaviors; epidemiologic, behavioral, health services, and 
laboratory research on HIV/AIDS, viral hepatitis, and other STDs; 
identification of policy issues related to HIV/viral hepatitis/STD 
professional eduction, patient healthcare delivery, and prevention 
services; HHS policies about prevention of HIV/AIDS, viral hepatitis 
and other STDs; treatment, healthcare delivery, and research and 
training; strategic issues influencing the ability of CDC and HRSA to 
fulfill their missions of providing prevention and treatment services; 
programmatic efforts to prevent and treat HIV, viral hepatitis, and 
other STDs; and support to CDC and HRSA in their developoment of 
responses to emerging health needs related to HIV, viral hepatitis, and 
other STDs.
    During the March 30, 2017 meeting, the CDC/HRSA Advisory Committee 
on HIV, Viral Hepatitis and STD Prevention and Treatment will 
deliberate and vote on a proposed resolution regarding the HIV 
workforce, a proposal to expand the existing HCV (hepatitis C virus) 
Workgroup, and a proposal to develop an HIV Disparities Workgroup. 
Agenda items are subject to change as priorities dictate.
    Due to the nature and time limitations of the meeting, members of 
the public will not have an opportunity to provide oral comments. 
Individuals who need reasonable accommodations should notify CDR Holly 
Berilla at [email protected] at least 10 days prior to the meeting.

Jason E. Bennett,
Director, Division of the Executive Secretariat.
[FR Doc. 2017-04742 Filed 3-9-17; 8:45 am]
 BILLING CODE 4165-15-P